EXTL2 (Exostosin-like glycosyltransferase 2) is a pivotal enzyme that plays a crucial role in the biosynthesis of heparan sulfate. Heparan sulfate proteoglycans are complex molecules that participate in a multitude of biological functions, including cellular communication and the modulation of cell growth and proliferation. EXTL2 specifically catalyzes the chain elongation step of heparan sulfate, adding on repeating saccharide units to extend the polysaccharide chain. This elongation is vital for the proper functioning of heparan sulfate proteoglycans, which are integral to the extracellular matrix of cells and can influence the binding of growth factors and other molecules to the cell surface. The expression of EXTL2 is therefore a tightly regulated process within the cell, as it has to be synchronized with the intricate network of cellular activities and the overall demand for heparan sulfate chains.
Research into the regulation of EXTL2 expression has identified a variety of chemical compounds that can upregulate its activity within cells. These activators span a broad range of biochemical classes and exert their influence through diverse mechanisms. For instance, certain plant-derived polyphenols, such as resveratrol and epigallocatechin gallate, are known to engage with cellular signaling pathways, potentially leading to the upregulation of EXTL2 expression. Meanwhile, compounds like retinoic acid and vitamin D3 might interact with nuclear hormone receptors, which can bind to DNA and initiate transcriptional changes, including the possible induction of EXTL2. Moreover, small molecules that modify the epigenetic landscape of the cell, such as 5-Azacytidine and Trichostatin A, could lead to the demethylation of DNA or the acetylation of histones, respectively. These changes can render the EXTL2 gene more accessible to the transcriptional machinery, potentially resulting in increased levels of EXTL2 protein. It is important to note that the exact molecular interactions and the extent to which these compounds can induce the expression of EXTL2 require careful experimental investigation.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid can initiate transcription by binding to retinoic acid receptors, which may lead to the upregulation of genes involved in cell differentiation processes, including the potential increase in EXTL2 expression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
By inhibiting DNA methyltransferases, 5-Azacytidine can cause demethylation of genomic DNA, which could result in the reactivation of epigenetically silenced genes, potentially stimulating EXTL2 synthesis. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A, as a histone deacetylase inhibitor, facilitates a more transcriptionally active chromatin state, which may lead to the enhanced transcription of a range of genes, possibly including EXTL2. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin raises intracellular cAMP levels, which could trigger the activation of protein kinase A (PKA) and subsequent phosphorylation of transcription factors, potentially leading to increased EXTL2 gene expression. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $71.00 $163.00 $296.00 | 2 | |
The active form of Cholecalciferol can engage with the vitamin D receptor and may initiate the transcription of genes associated with calcium homeostasis, which could include the upregulation of EXTL2. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Present in green tea, epigallocatechin gallate may promote changes in DNA methylation and histone modification patterns, potentially leading to the activation of gene transcription, including that of EXTL2. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
DL-Sulforaphane has been observed to alter histone acetylation patterns, which may promote the transcriptional activation of certain genes, and could theoretically stimulate the expression of the EXTL2 gene. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin can activate transcription factors and signaling pathways, which could lead to a cascade of gene expression alterations, including the possible induction of EXTL2 expression. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol's ability to activate sirtuin pathways may lead to the transcriptional activation of certain genes, including the possibility of stimulating the expression of EXTL2. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium Chloride's inhibition of glycogen synthase kinase 3 (GSK-3) may initiate a series of transcriptional events that could culminate in the upregulation of EXTL2 expression. | ||||||